Self-sterilizing medical devices market seen growing to $1.88B by 2030

The Business Research Company says the self-sterilizing medical devices market will rise from $0.98 billion in 2025 to $1.11 billion in 2026, driven by infection-control demand and more surgical procedures. The report projects the market will reach $1.88 billion by 2030, with North America leading now and Asia-Pacific growing fastest.

Why it matters: - Self-sterilizing medical devices are aimed at lowering infection risk in clinical settings by reducing or eliminating microbial contamination on the device itself. - The market’s projected growth signals stronger demand for infection-prevention tools as hospitals face more pressure to reduce hospital-acquired infections and cross-contamination. - The report also points to rising use of reusable instruments and minimally invasive surgery as practical drivers of adoption.

What happened: - The Business Research Company released a 2026 market report on self-sterilizing medical devices. - The report estimates the market will grow from $0.98 billion in 2025 to $1.11 billion in 2026, a 13.7% CAGR. - The forecast calls for the market to reach $1.88 billion by 2030, with a 14.0% CAGR. - North America held the largest regional share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample is available here. - The full report is available here.

The details: - Self-sterilizing medical devices use built-in technologies to reduce or eliminate contamination without relying on external sterilization. - Common approaches include antimicrobial coatings, ultraviolet light and self-cleaning surface technologies. - The report says historic growth has been driven by more hospital-acquired infections, stricter surgical hygiene standards, more reusable medical instruments, expanding hospital infrastructure in emerging markets and early adoption of antimicrobial coatings. - The report says future growth will be supported by self-disinfecting materials, autonomous infection-prevention systems, more minimally invasive surgery and stronger efforts to reduce cross-contamination. - Key trends include UV-C embedded sterilization in reusable instruments, antimicrobial coating innovation, tighter hospital-acquired infection prevention protocols, more regulatory validation requirements for autonomous sterilization and biocompatible self-disinfecting surfaces for long-term clinical use. - The report highlights hospital-acquired infections as a major demand driver because these infections develop during treatment in healthcare facilities and are linked to weak infection-control practices. - The Australian Institute of Health and Welfare reported in November 2024 that hospital-acquired complications affected 115,000 public hospitalizations and 34,200 private hospitalizations in Australia during 2022–23, with healthcare-associated infections accounting for 37% of those complications. - The report also ties market growth to the rising number of surgical procedures. - Intuitive Surgical said about 2,683,000 surgeries were performed using da Vinci systems in early 2024, up from 2,286,000 in 2023 and 1,875,000 in 2022. - Rising healthcare spending is another supporting factor. - The Centers for Medicare and Medicaid Services said US healthcare expenditures rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person.

Between the lines: - The report frames self-sterilizing devices as part of a broader shift toward continuous infection control, not just one-time sterilization. - The focus on regulatory validation suggests the market is moving from early adoption toward tighter proof standards, which could shape which technologies scale fastest. - The regional split points to mature demand in North America and faster expansion potential in Asia-Pacific as healthcare infrastructure develops.

What's next: - The report expects demand to accelerate through 2030 as hospitals look for autonomous infection-prevention tools and more durable antimicrobial materials. - Broader use of reusable instruments and robotic-assisted surgery may increase demand for devices that can help reduce infection risk during repeated clinical use. - The Business Research Company’s report package also includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated graphics and tables.